Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
A Study of the Safety and Effectiveness of Ustekinumab (Stelara) in Chinese Patients With Psoriasis
This study has been completed.
Study NCT01008995 Information provided by Centocor, Inc.
First Received on November 5, 2009. Last Updated on October 17, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
More general conditions related to this trial
Skin Diseases, Papulosquamous
Interventions listed in this trial
Sponsors listed in this trial
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers